Fact CheckerSign in

NCT06118112Completed

Living With Long COVID: LONGCOVID-EXPERIENCE

Living With Long COVID: LONGCOVID-EXPERIENCE Qualitative Study

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence for at least two months, without being explained by an alternative diagnosis. The characteristics and clinical approach to persistent COVID syndrome are fairly well known, but not what the experience of people with persistent COVID is in relation to their daily life, their work life, and their experience with the healthcare received. Objective: to understand the experience of patients with persistent COVID in relation to the disease, the health care received and re-entry into the world of work Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.

Status (registry)
Completed
Study type
Observational
Enrollment
25 (actual)
First submitted
15 Sept 2023
Start date
18 Sept 2023
Primary completion date
30 Jun 2024
Lead sponsor
Corporacion Parc Tauli
NCT number
NCT06118112

What you commit to

  • Study type: Observational
  • Participants enrolled: 25
  • From 18 Sept 2023 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • -people who do not understand or can communicate in Catalan or Spanish.

Who the study is looking for

  • women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis).
  • treated at the Parc Taulí Hospital
  • from 18 to 65 years

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Corporacio Sanitaria Parc Tauli
Coordinator of this site? Confirm its status
SabadellSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.